Cyclooxygenases-1 and -2 (COX-1 and COX-2) catalyze the committed step in the conversion of arachidonic acid to prostaglandins (PGs) and thromboxane. COX-1 is constitutively expressed in many tissues and appears to play a role in homeostatic functions whereas COX-2 is highly regulated in response to a range of agonists and appears to contribute to pathophysiological responses. Selective inhibition of COX-2 has been exploited for the development of anti-inflammatory compounds with reduced gastrointestinal toxicities. However, the recent recognition of cardiovascular toxicity associated with the clinical use of these agents suggests that the role of COX-2 in normal physiology has not been fully appreciated. The major functional differences between COX-1 and COX-2 have primarily been attributed to their differential expression. However, we have shown that COX-2 is able to oxygenate a range of neutral derivatives of arachidonic acids, including the endocannabinoid, 2-arachidonylglycerol (2-AG). COX-2-dependent oxygenation of 2-AG leads to the formation of a range of glyceryl esters of PGs (PG-Gs) that is nearly as diverse as the PGs themselves. PG-G formation occurs in macrophage populations responding to inflammatory stimuli, and PGE2-G induces Ca2+ mobilization in RAW264.7 cells, supporting the hypothesis that PG-Gs represent a new class of lipid mediators. Here we propose to further exploit the resources of the Research Center for Pharmacology and Drug Toxicology to answer key remaining questions concerning the possible physiological roles of PG-Gs in vivo. We will 1) apply lipidomics and RNAi technology to monitor total lipid changes in macrophages during PG-G synthesis in order to identify the lipid pools that give rise to 2-AG and the specific enzymes that regulate 2-AG formation. 2) perform detailed kinetic studies of the interaction of hydroperoxy glyceryl esters with COX-2 in order to determine if PGG2-G, the immediate product of COX-2 oxygenation of 2-AG, differs from PGG2 in its ability to activate or inactivate the enzyme;3) characterize PGG formation by rabbit renal medullary interstitial cells, which appear to be a potential source of large quantities of PG-Gs that may be important in the regulation of renal function under hypertonic conditions;4) characterize PGE2-G metabolism in the monkey in vivo to identify unique metabolites of PG-Gs that can be used to quantify in vivo biosynthesis of these compounds in humans. These experiments will provide critical information toward the development of a better understanding of the role of PG-Gs in vivo, and will help test the hypothesis that PG-G synthesis represents a unique physiologic function of COX-2.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM015431-43
Application #
8104164
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
43
Fiscal Year
2010
Total Cost
$345,223
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Salisbury-Ruf, Christi T; Bertram, Clinton C; Vergeade, Aurelia et al. (2018) Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Elife 7:
Kong, Deping; Li, Juanjuan; Shen, Yujun et al. (2017) Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. J Pharmacol Exp Ther 360:435-444
Teder, Tarvi; Boeglin, William E; Brash, Alan R (2017) Oxidation of C18 Hydroxy-Polyunsaturated Fatty Acids to Epoxide or Ketone by Catalase-Related Hemoproteins Activated with Iodosylbenzene. Lipids 52:587-597
Plewes, Katherine; Kingston, Hugh W F; Ghose, Aniruddha et al. (2017) Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study. BMC Infect Dis 17:313
Kudalkar, Shalley N; Kingsley, Philip J; Marnett, Lawrence J (2016) Assay of Endocannabinoid Oxidation by Cyclooxygenase-2. Methods Mol Biol 1412:205-15
Wu, Jing; Montaniel, Kim Ramil C; Saleh, Mohamed A et al. (2016) Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Hypertension 67:461-8
Wu, Jing; Saleh, Mohamed A; Kirabo, Annet et al. (2016) Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest 126:50-67
Mashhadi, Zahra; Newcomer, Marcia E; Brash, Alan R (2016) The Thr-His Connection on the Distal Heme of Catalase-Related Hemoproteins: A Hallmark of Reaction with Fatty Acid Hydroperoxides. Chembiochem 17:2000-2006
Kong, Deping; Shen, Yujun; Liu, Guizhu et al. (2016) PKA regulatory II? subunit is essential for PGD2-mediated resolution of inflammation. J Exp Med 213:2209-26
Boutaud, Olivier; Sosa, I Romina; Amin, Taneem et al. (2016) Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prev Res (Phila) 9:855-865

Showing the most recent 10 out of 147 publications